Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
2.
J Anim Sci ; 97(4): 1784-1795, 2019 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-30753502

RESUMEN

An experiment was conducted to evaluate growth performance, fecal bacterial counts, frequency of diarrhea, and clinical blood parameters in weanling pigs inoculated with enterotoxigenic Escherichia coli (ETEC) who were fed a whole yeast cell (WYC) product and capsicum, a plant essential oil. Weanling pigs (34 barrows and 30 gilts, 21 d of age, 5.90 ± 1.03 kg BW) were allotted to experimental treatments in a randomized complete block design based on litter, sex, and initial BW. Four pigs were individually housed within each containment chamber and assigned to 1 of 4 dietary treatments, which included a control diet without or with 0.2% WYC (CitriStim; ADM, Decatur, IL) or 10 ppm of capsicum (XTract 6933; Pancosma, Geneva, Switzerland), provided either alone or in combination. After receiving diets for 13 d, pigs were orally inoculated with F18+ ETEC and maintained on their assigned diets for an additional 10 d; a separate cohort of 12 pigs receiving the control diet was sham-inoculated using PBS. Body and feeder weights were recorded, and fecal swabs collected, on 0, 5, and 10 d postinoculation (DPI), with blood sampled at 0, 2, 7, and 10 DPI for isolation of peripheral blood mononuclear cells. Pigs challenged with ETEC and fed diets containing WYC or capsicum alone had a higher frequency of diarrhea when compared with pigs receiving diets without those compounds (P < 0.05). Total fecal bacterial counts in pigs fed the combination of additives were highest when compared with either additive alone (interaction, P = 0.03) at 10 DPI. Blood leukocyte counts were increased in challenged pigs receiving the combination of additives compared with all other challenged treatment groups (interaction, P = 0.04). The addition of WYC increased (main effect, P = 0.01) lymphocyte counts at 7 DPI. Proportions of CD8+ and CD4+CD8+ cells were lower in pigs fed the combination of additives compared with pigs fed either additive alone at 0 and 7 DPI. In conclusion, these data indicate that the combination of the 2 additives elicited higher ETEC shedding and circulating leukocyte counts, and reduced the proportions of cytotoxic and memory T-cells than either additive alone.


Asunto(s)
Capsicum/química , Escherichia coli Enterotoxigénica/inmunología , Infecciones por Escherichia coli/veterinaria , Aceites Volátiles/farmacología , Enfermedades de los Porcinos/inmunología , Levaduras/inmunología , Alimentación Animal/análisis , Animales , Estudios de Cohortes , Diarrea/veterinaria , Dieta/veterinaria , Infecciones por Escherichia coli/inmunología , Heces/microbiología , Femenino , Inmunomodulación/efectos de los fármacos , Leucocitos Mononucleares/efectos de los fármacos , Masculino , Aceites de Plantas/farmacología , Distribución Aleatoria , Porcinos
3.
J Med Food ; 13(4): 863-9, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20553181

RESUMEN

Humic acids are compounds resulting from decomposition of organic matter. Despite their common presence, our knowledge of their biological effects is limited, and current findings are controversial. We decided to evaluate the immunological effects of two different types of humic acids, differing in source and biochemical characteristics. Using both components either alone or in combination with the well-established yeast-derived immunomodulator glucan, we measured their effects on both the cellular (phagocytosis and tumor suppression) and humoral (antibody production and cytokine secretion) branches of immune reactions. In summary, our results suggest that humic acids are biologically active immunodulators affecting both the humoral and cellular branches of immune reactions. In addition, the two humic acids studied here are working in synergy in stimulation of the immune reaction, supporting further studies of these natural immunomodulators.


Asunto(s)
Glucanos/inmunología , Sustancias Húmicas/análisis , Sistema Inmunológico/efectos de los fármacos , Sistema Inmunológico/inmunología , Factores Inmunológicos/farmacología , Animales , Citocinas/inmunología , Sinergismo Farmacológico , Femenino , Glucanos/farmacología , Inmunidad Celular/efectos de los fármacos , Inmunidad Humoral/efectos de los fármacos , Factores Inmunológicos/análisis , Ratones , Ratones Endogámicos BALB C , Fagocitosis/efectos de los fármacos , Levaduras/química , Levaduras/inmunología
4.
Inflammopharmacology ; 18(3): 147-54, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20069379

RESUMEN

The leaves of Cinnamomum tamala Linn (Lauraceae), component of Indian spices are associated with hypoglycemic property in Ayurveda; however, no report is available towards its immunomodulation property, which has been explored here. The dried powder of CT leaves was extracted with hexane and solvent free extract (CTH) was given orally to rats for 10 days, in various doses. Its effect was studied on peritoneal macrophage functions, and was compared with ascorbic acid (1,000 mg/kg, immune-stimulant) and cyclophosphamide (10 mg/kg, immune-suppressant). CTH significantly suppressed phagocytosis activity (EC(50) 2,355 +/- 52.45 mg/kg), reduced production of superoxide (EC(50) 275.91 +/- 10.21 microg/ml) and cellular NADPH (EC(50) 384.959 +/- 4.85 microg/ml) content in concentration dependent manner. It also inhibited LPS induced production of nitric oxide (EC(50) 143.75 +/- 3.40 microg/ml) and iNOS protein expression (EC(50) 183.132 microg/ml). Thus, it could be suggested that non-polar hexane fraction of leaves of C. tamala possesses immunosuppressive property, which is mediated through modulation of innate immunity.


Asunto(s)
Cinnamomum/química , Hexanos/química , Macrófagos Peritoneales/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta/química , Animales , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/farmacología , Supervivencia Celular/efectos de los fármacos , Ciclofosfamida/administración & dosificación , Ciclofosfamida/farmacología , Dexametasona/farmacología , Flavonoides/análisis , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/citología , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , NADP/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fagocitosis/efectos de los fármacos , Fagocitosis/inmunología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Ratas , Ratas Endogámicas , Estallido Respiratorio/efectos de los fármacos , Superóxidos/metabolismo , Terpenos/análisis , Levaduras/inmunología
5.
Posit Health News ; (No 17): 22-3, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-11366551

RESUMEN

AIDS: Research published to date on beta glucan's immunological effects has been conflicting. The compound is extracted from sprouted oats and baker's yeast. All forms of it have been found to activate macrophage function needed to clear bacterial infections. Persons with active bacterial and fungal infections are expected to benefit from using beta glucan. Suggested dosing information is included.^ieng


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Infecciones Bacterianas/terapia , Terapias Complementarias , Glucanos/farmacología , Animales , Infecciones Bacterianas/metabolismo , Citocinas/metabolismo , Citotoxicidad Inmunológica , Dinitroclorobenceno/administración & dosificación , Glucanos/administración & dosificación , Humanos , Inmunidad Celular , Células Asesinas Naturales/inmunología , Ratones , Levaduras/inmunología
6.
Vopr Virusol ; 39(1): 21-4, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-8160443

RESUMEN

Experiments in BALB/c mice were carried out to study a number of immunomodulators in combination with vaccination using a recombinant yeast hepatitis B vaccine. The use of poludan, ridostine, amixine, larifan, myekonide significantly enhanced specific antibody production and at least doubled cell-mediated immune response by 14 and 28 days postvaccination. The above-mentioned immunomodulators are planned to be used in vaccination with the recombinant yeast vaccine against hepatitis B.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Vacunas Fúngicas/inmunología , Vacunas contra Hepatitis B/inmunología , Hepatitis B/prevención & control , Vacunas Sintéticas/inmunología , Levaduras/inmunología , Animales , Evaluación Preclínica de Medicamentos , Hepatitis B/inmunología , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/inmunología , Inmunización/métodos , Ratones , Ratones Endogámicos BALB C , Factores de Tiempo
7.
Sabouraudia ; 20(2): 115-25, 1982 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7051368

RESUMEN

Several yeast species in the genera Candida, Saccharomyces and Cryptococcus showed powerful immunoadjuvant, chemotherapy-synergic effects against a histocompatible, virus-induced murine lymphoma. Sensitizing and booster intraperitoneal injections of 2 x 10(7) yeast cells on days -14 and +1 (with respect to tumor challenge on day 0) followed by treatment with antiblastic drugs (on day +5) were required to elicit optimum activity. The antitumor effect was not markedly influenced by the morphological growth form of merthiolate-inactivated C. albicans nor by the nature of the carbon source in the growth medium, except for C. albicans cells grown in a medium containing stearic acid, which were not effective. These cells had a higher ratio of soluble to insoluble cell wall components, as compared to glucose-grown cells, but this finding alone could hardly explain the lack of antitumor effects. Previous observations, suggesting that the alkali-acid insoluble beta-glucan (in the form of cell wall ghosts) is the only component of yeast cell walls endowed with antitumor activity comparable to that of whole cells, were confirmed and extended; the soluble mannan and glucan-protein fractions were unable to replace whole cells and glucan ghosts even as sensitizers or as boosting agents.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antineoplásicos/uso terapéutico , Glucanos/inmunología , Linfoma/terapia , Levaduras/inmunología , Animales , Candida albicans/análisis , Candida albicans/citología , Candida albicans/inmunología , Carmustina/uso terapéutico , Pared Celular/análisis , Cryptococcus/inmunología , Medios de Cultivo , Fluorouracilo/uso terapéutico , Ratones , Neoplasias Experimentales/terapia , Saccharomyces
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA